Lv4
730 积分 2024-12-24 加入
Endo-histologic outcomes in patients with ulcerative colitis responding to tofacitinib
7个月前
已完结
Efficacy and safety of tofacitinib for the treatment of moderate-to-severe ulcerative colitis in biologic-naive patients
7个月前
已关闭
Real-World Experience of Upadacitinib Reinduction and High Dose Maintenance Therapy in Inflammatory Bowel Disease
7个月前
已关闭
Upadacitinib for Induction of Remission in Pediatric Ulcerative Colitis: An International Multi‑center Study
7个月前
已完结
Upfront tofacitinib in patients with biological-naïve ulcerative colitis – An Indian multicentric experience
7个月前
已完结
Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian Study
7个月前
已完结
Tofacitinib en el tratamiento de la colitis ulcerosa moderada a severa en Colombia: Experiencia en mundo real
7个月前
已关闭
Efficacy and safety of filgotinib for ulcerative colitis: A real‐world multicenter retrospective study in Japan
7个月前
已完结
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study
7个月前
已完结
Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes
7个月前
已完结
皖公网安备34019202002308
